Let us run your inhibitor screens or determine dose-response against our extensive suite of target assays. Our experienced team will provide extensive data reporting within several weeks, combining powerful results with utmost convenience.
Targeted Solutions for the Development of TCR-based Adoptive Cell Therapy
Check out our new suite of tools to help advance TCR development projects targeting NY-ESO1, MART-1, KRAS G12D, and MAGE-A1, including antigen-specific TCR reporter cell lines, lentiviruses, TCR knock-out cell lines, and peptides.
Discover our newest solution for finding potent effectors in DNA damage repair pathways with our PARG assay kit, a homogeneous, fluorogenic assay ideal for high-throughput screening.
Find our new TL1A-Responsive Luciferase Reporter Jurkat Cell Line, stably expressing DR3 and an NF-kB promoter that drives luciferase production upon activation.
Luciferase Reporter Cells for Diabetes & Obesity Research
